Efficacy and safety of edifoligide

JAMA. 2006 Apr 5;295(13):1513-4; author reply 1514-5. doi: 10.1001/jama.295.13.1513-b.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coronary Artery Bypass*
  • DNA / therapeutic use*
  • E2F Transcription Factors*
  • Genetic Therapy*
  • Graft Occlusion, Vascular / prevention & control*
  • Humans
  • Oligonucleotides / therapeutic use*
  • Saphenous Vein / drug effects*
  • Saphenous Vein / transplantation*
  • Transplants*
  • Vascular Patency / drug effects*

Substances

  • E2F Transcription Factors
  • Oligonucleotides
  • edifoligide
  • DNA